Combination therapy of interferon-alpha and interleukin-2 for patients with metastatic renal cell carcinoma after failure of targeted therapy because of adverse events
Not Applicable
Recruiting
- Conditions
- metastatic renal cell carcinoma
- Registration Number
- JPRN-UMIN000017717
- Lead Sponsor
- Department of Urology, The University of Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. allergic reaction for biological products such as vaccine 2. autoimmune hepatitis 3. interstitial pneumonitis 4. female during pregnancy or lactation 5. receiving steroid hormone therapy 6. progressive disease during prior targeted therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method